Your browser doesn't support javascript.
loading
GLOS and HARM in patients with transient neurovascular symptoms with and without ischemic infarction.
Förster, A; Ramos, Ana; Wenz, H; Böhme, J; Groden, C; Alonso, A.
Afiliación
  • Förster A; Department of Neuroradiology, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany. Electronic address: Alex.Foerster@umm.de.
  • Ramos A; Department of Neuroradiology, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
  • Wenz H; Department of Neuroradiology, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
  • Böhme J; Department of Neuroradiology, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
  • Groden C; Department of Neuroradiology, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
  • Alonso A; Department of Neurology, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
J Neuroradiol ; 49(3): 244-249, 2022 May.
Article en En | MEDLINE | ID: mdl-33836217
BACKGROUND AND PURPOSE: Gadolinium leakage in ocular structures (GLOS) on fluid attenuated inversion recovery images (FLAIR) is a novel imaging marker in acute ischemic stroke and other neurological disorders. METHODS: In patients with transient neurovascular symptoms who underwent repeated MRI with intravenous contrast agent administration, the presence of acute ischemic lesions on diffusion-weighted images (DWI) as well as the frequency and pattern of blood-brain barrier and blood-retina barrier impairment as demonstrated by the hyperintense acute reperfusion marker (HARM) and GLOS respectively on postcontrast FLAIR were evaluated. RESULTS: Overall 28 patients with transient neurovascular symptoms (median age 70.5 years; 18 (64.3%) male) were included. Follow-up MRI was performed within 35 (IQR 21-47) hours after the initial MRI. On DWI, acute ischemic lesions were observed in 22 (78.6%). On contrast-enhanced FLAIR, GLOS was observed in 12 (42.9%) patients: in 1 (3.6%) only in the anterior chamber, and in 11 (39.3%) in the anterior chamber and vitreous body. HARM was observed in 3 (10.7%) patients. In one patient without ischemic lesion on DWI or HARM on FLAIR, GLOS was observed in the anterior chamber and vitreous body. Presence of GLOS was associated with higher age (p = 0.04) and detection of HARM (p = 0.03). CONCLUSIONS: In patients with transient neurovascular symptoms, GLOS is a frequent finding and associated with HARM on contrast-enhanced FLAIR. As GLOS was observed in one patient without an ischemic lesion or HARM, it might be useful as an additional imaging marker.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Tipo de estudio: Diagnostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Neuroradiol Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Tipo de estudio: Diagnostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Neuroradiol Año: 2022 Tipo del documento: Article